688266: Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266) intends to acquire the holding subsidiary gensun biopharama Inc. in cash Gensun biopharama Inc Asset appraisal report on the value of all shareholders’ equity

688266: Suzhou Zelgen Biopharmaceuticals Co.Ltd(688266) intends to acquire the holding subsidiary gensun biopharama Inc. in cash Gensun biopharama Inc Statement 1 of the asset appraisal report on the value of all shareholders’ rights and interests 1. This asset appraisal report is prepared in accordance with the basic standards for asset appraisal issued by the Ministry of Finance and the asset appraisal practice standards and professional ethics standards issued by China Asset Appraisal Association. 2、 The client or other users of the asset appraisal report shall use the asset appraisal report in accordance with the provisions of laws, administrative regulations and the scope of use specified in the asset appraisal report; If the client or other users of the asset appraisal report use the asset appraisal report in violation of the above provisions, the asset appraisal institution and asset appraisal professionals shall not be liable